Navigation Links
Sanofi-aventis Delivers 2008 Results Above Guidance
Date:2/11/2009

PARIS, Feb. 11 /PRNewswire-FirstCall/ --

                               FY 2008    % change     Q4 2008      % change
                               -------    --------     -------      --------
    Comparable net sales*:   EUR27,568m      +3.7%     EUR7,089m       +3.6%
    Adjusted net income
     excluding selected
    items(1):                 EUR7,186m      +3.2%     EUR1,627m      +13.9%
    Adjusted EPS excluding     EUR5.49       +6.2%      EUR1.25       +16.8%
    selected items(1):

In order to facilitate the understanding of the Group's operational performance, we comment adjusted income statement excluding selected items (1), a non-GAAP financial measure. 2008 fourth-quarter and full-year consolidated income statements are provided in appendix 4, as are details of adjustments and selected items. Consolidated net income for 2008 was EUR 3,851 million, compared with EUR 5,263 million in 2007, the decline being mainly due to an impairment charge of EUR 1,485 million taken against intangible assets related to the acquisition of Aventis.

2008 performance

  • EPS(2) growth at constant euro/dollar exchange rates above guidance (up 11.2% against guidance of around 9%)
  • Solid sales performance driven by Lantus(R) (up 27.7%), Taxotere(R) (up 13.2%), Lovenox(R) (up 10.6%), Plavix(R) (up 10.5%), Aprovel(R) (up 14.2%) and vaccines (up 9.6%)
  • Successful launch of Pentacel(R) and filing for approval of Multaq(R) and Ciltyri(R) in the United States and Europe
  • Growth ahead of the market in the United States, and double-digit growth in emerging markets and in Japan
  • Continued improvement in operating ratios
  • Net debt reduced to EUR 1.8 billion
  • Proposed dividend of EUR 2.20 per share, payable April 28, 2009


'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
2. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
3. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
4. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
5. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
6. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
7. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
8. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
9. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
10. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
11. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 13, 2014 (HealthDay News) -- Eye tests could be ... Alzheimer,s disease, two new studies suggest. In one ... certain eye test found a significant association between levels ... and levels of the plaques in the brain. Beta-amyloid ... This type of eye test could be used ...
(Date:7/14/2014)... MONDAY, July 14, 2014 (HealthDay News) -- Being physically ... risk for Alzheimer,s disease and other types of dementia, ... our studies, we found that physical exercise at various ... Dr. Yonas Geda from the Mayo Clinic, said in ... results, but they are not yet conclusive. More research ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July 14, 2014 ... multiple health issues, but dementia isn,t one of them, according ... even delay dementia, the researchers found. "For those who ... with a later age of developing full-blown dementia compared to ... Woodruff, an assistant professor of neurology at the ...
(Date:7/14/2014)... 14, 2014 Follow ... liquid chromatography or UPLC is a new ... chromatography that involves the use of extremely ... separate chromatographic compounds. This highly sensitive qualitative ... and analysis of chromatography samples. UPLC functions ...
(Date:7/14/2014)... Clara, California (PRWEB) July 14, 2014 ... America for the 6th Annual 5K run and one-mile ... America, winds through the park attractions, and finishes inside ... event has raised over $150,000 for the Mission City ... throughout Santa Clara County. , Seasoned athletes, part-time ...
Breaking Medicine News(10 mins):Health News:Eye Tests Might Help ID Alzheimer's, Studies Suggest 2Health News:Staying Active May Help Prevent Dementia 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2
... on its services for individuals living with autism, and sharing the results ... the services and supports that families living with autism desperately need. ... ... shining the spotlight on its services for individuals living with autism, and ...
... the Family" with Allen Cardoza , Los Angeles, ... ANGELES, April 2 Our special guest this week ... successful private practice. Shelly has been a coach and ... corporate organizations as a Doctor of Psychology and a ...
... how a small hospital improved charge capture performance, ... using Craneware,s Bill AnalyzerATLANTA, April 2 Craneware, ... of financial performance solutions, announced today it will ... at the annual conference of the Healthcare Information ...
... The following is a statement from Jeff Levi, PhD, ... to the release of the new report Beyond Health ... Wood Johnson Foundation Commission to Build a Healthier America:"Every American ... or she can be. And every community should be ...
... Take Place on May 2; ... on May 9 LOS ANGELES, April 2 Revlon (NYSE: REV ... Jennifer Connelly and Jessica Alba along with NBC late night host ... in New York taking place on Saturday, May 2, 2009 , while ...
... with the glitazone class of diabetes drugs leads to ... edema (DME)a common complication that can lead to vision ... the American Journal of Ophthalmology ( http://www.elsevier.com/locate/ajo ... about 170,000 patients with diabetes, Drs. Donald S. Fong ...
Cached Medicine News:Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 2Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 3Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 4Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 5Health News:Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 2Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 4Health News:Diabetes drug class linked to vision-threatening complication 2
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... analysis approaches are evolving across industry sectors to ... now examining better ways to engage with and ... consumers inform themselves and make critical purchasing decisions. ... benchmarking firm, Best Practices, LLC, one area where ...
(Date:7/11/2014)... Research and Markets  has announced the ... report to their offering. ... a hollow needle commonly used with a syringe to ... fluids from it. A hypodermic needle is used for ... cannot be ingested. Hypodermic needles are broadly classified into ...
(Date:7/11/2014)... July 11, 2014 According to ... "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization ... and Forecast, 2013-2019" the global endoscopy devices market was ... expected to grow at a CAGR of 6.8% from ... USD 36.9 billion in 2019. Browse the ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... a low osmolar ionic dimer. Each ... meglumine, 196 mg of ioxaglate sodium ... disodium as a stabilizer. The solution ... each milliliter and provides 32% (320 ...
... IMAGOPAQUE is a non-ionic monomeric contrast ... in adults and children. After a decade ... 3.5 million examinations, IMAGOPAQUE has proven to ... effort in hundreds of radiology departments.Results from ...
... is a liver-specific contrast agent approved for ... Its introduction expands the Amersham Health portfolio ... injected intravenously, TESLASCAN aids in the detection, ... Imaging can begin within minutes of injection, ...
... a new Contrast Agent for ... of stabilized SF6 microbubbles. The ... between 1 and 10 m, ... 2 and 5 x 108 ...
Medicine Products: